AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Alsita-M 50 Forte Tablet ER

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Alsita-M 50 Forte Tablet ER

For individuals with type 2 diabetes, Fortadia-50 extended-release tablets offer a dual-action approach to managing elevated blood glucose. This combination therapy helps mitigate the risk of serious diabetic complications like vision impairment and kidney disease, potentially lowering the probability of cardiovascular events. Fortadia-50 may be used independently or in conjunction with other diabetes treatments, achieving optimal results when coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management, as lifestyle significantly impacts blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headaches, and sore throat. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; patients must be able to identify and manage this condition. This medication is not universally suitable. Prior to commencing treatment, individuals with pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption should inform their physician. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate comprehensive disclosure of all current medications to ensure patient safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Regular monitoring of kidney function and blood sugar levels is conducted throughout the treatment period.

Uses of Alsita-M 50 Forte Tablet ER

Managing type 2 diabetes

Major Benefits of Alsita-M 50 Forte Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Alsita-M 50 Forte Tablet ER with a meal.

Common Side effects of Alsita-M 50 Forte Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Alsita-M 50 Forte Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Alsita-M 50 Forte Extended-Release Tablet should be administered with a meal.

How Alsita-M 50 Forte Tablet ER works:

Alsita-M 50 Forte Extended-Release tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Alsita-M 50 Forte Tablet ER and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Alsita-M 50 Forte tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Alsita-M 50 Forte tablets may pose a risk during lactation. Available human data indicates potential transfer to breast milk, potentially harming the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Alsita-M 50 Forte Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.

LiverLiverUNSAFE

Extended-release Alsita-M 50 Forte tablets are contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Alsita-M 50 Forte Tablet ER :

Should you forget a dose of Alsita-M 50 Forte Tablet ER, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alsita-M 50 Forte Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Alsita-M 50 Forte Tablet ER

Alsita-M 50 Forte ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Alsita-M 50 Forte Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as numbness, tingling in extremities, weakness, and urinary issues), and cognitive changes (including balance problems), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Alsita-M 50 Forte Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Alsita-M 50 Forte Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Alsita-M 50 Forte Tablet ER and alcohol is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Yes, Alsita-M 50 Forte Tablet ER (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Alsita-M 50 Forte ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Alsita-M 50 Forte Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Alsita-M 50 Forte Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Alsita-M 50 Forte Tablet ER and alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Alsita-M 50 Forte Tablet ER. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol, hence its avoidance in such individuals. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Alsita-M 50 Forte Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, yearly supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Alsita-M 50 Forte ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Alsita-M 50 Forte Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Alsita-M 50 Forte Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Alsita-M 50 Forte Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Alsita-M 50 Forte Tablet ER. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Alsita-M 50 Forte Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Alsita-M 50 Forte Tablet ...
127